|
|
PGM3 |
phosphoglucomutase 3 |
- Synthesis of UDP-N-acetyl-glucosamine
|
|
|
|
|
PHACTR4 |
phosphatase and actin regulator 4 |
|
|
|
|
|
PHAF1 |
phagophore assembly factor 1 |
|
|
|
|
|
PHF20L1 |
PHD finger protein 20 like 1 |
- Formation of WDR5-containing histone-modifying complexes
|
|
|
|
|
PHF7 |
PHD finger protein 7 |
|
|
|
|
|
PHF8 |
PHD finger protein 8 |
- HDMs demethylate histones
|
|
- Syndromic X-linked mental retardation, including: Turner type (MRXST); Siderius type (MRXSSD) ; Cabezas type (MRXC); Raymond type (MRXSR); Type10 (MRXS10); Type14 (MRXS14); Mental retardation with isolated growth hormone deficiency (MRGH)
|
|
|
PHGDH |
phosphoglycerate dehydrogenase |
|
|
|
|
|
PHLDA1 |
pleckstrin homology like domain family A member 1 |
- Interaction between PHLDA1 and AURKA
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
|
|
|
|
|
PHLDA3 |
pleckstrin homology like domain family A member 3 |
|
|
|
|
|
PHYH |
phytanoyl-CoA 2-hydroxylase |
- Alpha-oxidation of phytanate
- Peroxisomal protein import
- Peroxisomal protein import
- TYSND1 cleaves peroxisomal proteins
|
- Antihemophilic factor, human recombinant
- Ascorbic acid
- Lonoctocog alfa
- Moroctocog alfa
|
- Refsum disease; Heredopathia atactica polyneuritiformis
|
|
|
PHYHD1 |
phytanoyl-CoA dioxygenase domain containing 1 |
|
|
|
|
|
PI4K2A |
phosphatidylinositol 4-kinase type 2 alpha |
- Synthesis of PIPs at the plasma membrane
- Synthesis of PIPs at the Golgi membrane
- Synthesis of PIPs at the early endosome membrane
|
|
|
|
|
PIBF1 |
progesterone immunomodulatory binding factor 1 |
|
|
|
|
|
PIGG |
phosphatidylinositol glycan anchor biosynthesis class G (EMM blood group) |
- Synthesis of glycosylphosphatidylinositol (GPI)
|
|
|
|
|
PIGO |
phosphatidylinositol glycan anchor biosynthesis class O |
- Synthesis of glycosylphosphatidylinositol (GPI)
|
|
|
|
|
PIK3R2 |
phosphoinositide-3-kinase regulatory subunit 2 |
- PI3K Cascade
- IRS-mediated signalling
- GPVI-mediated activation cascade
- PIP3 activates AKT signaling
- Interleukin-7 signaling
- Interleukin-7 signaling
- Signaling by SCF-KIT
- Synthesis of PIPs at the plasma membrane
- Downstream signal transduction
- PI3K/AKT activation
- Signaling by ALK
- Downstream TCR signaling
- Role of phospholipids in phagocytosis
- Tie2 Signaling
- Constitutive Signaling by Aberrant PI3K in Cancer
- DAP12 signaling
- Role of LAT2/NTAL/LAB on calcium mobilization
- Nephrin family interactions
- CD28 dependent PI3K/Akt signaling
- G alpha (q) signalling events
- VEGFA-VEGFR2 Pathway
- VEGFA-VEGFR2 Pathway
- Interleukin-3, Interleukin-5 and GM-CSF signaling
- RAF/MAP kinase cascade
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- RET signaling
- RHOA GTPase cycle
- Extra-nuclear estrogen signaling
- RHOB GTPase cycle
- CDC42 GTPase cycle
- RAC1 GTPase cycle
- RAC2 GTPase cycle
- RHOD GTPase cycle
- RHOJ GTPase cycle
- RHOU GTPase cycle
- RAC3 GTPase cycle
- RHOF GTPase cycle
- Interleukin receptor SHC signaling
- Regulation of signaling by CBL
- Regulation of signaling by CBL
- Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
- Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
- Signaling by PDGFRA extracellular domain mutants
- RND3 GTPase cycle
- RND2 GTPase cycle
- RND1 GTPase cycle
- Signaling by ALK fusions and activated point mutants
- Signaling by LTK in cancer
- Signaling by LTK
- High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
- Co-stimulation by ICOS
|
|
|
|
|
PIK3R5 |
phosphoinositide-3-kinase regulatory subunit 5 |
- GPVI-mediated activation cascade
- PIP3 activates AKT signaling
- Synthesis of PIPs at the plasma membrane
- Constitutive Signaling by Aberrant PI3K in Cancer
- CD28 dependent PI3K/Akt signaling
- G beta:gamma signalling through PI3Kgamma
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
- Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
- Co-stimulation by ICOS
|
|
|
|
|
PIKFYVE |
phosphoinositide kinase, FYVE-type zinc finger containing |
- Synthesis of PIPs at the Golgi membrane
- Synthesis of PIPs at the Golgi membrane
- Synthesis of PIPs at the early endosome membrane
- Synthesis of PIPs at the early endosome membrane
- Synthesis of PIPs at the late endosome membrane
- Synthesis of PIPs at the late endosome membrane
|
|
- Fleck corneal dystrophy (FCD); Francois-Neetens speckled corneal dystrophy
|
|
|
PIM1 |
Pim-1 proto-oncogene, serine/threonine kinase |
- Interleukin-4 and Interleukin-13 signaling
- STAT5 activation downstream of FLT3 ITD mutants
- Signaling by FLT3 fusion proteins
|
- 3,4-Dihydroxy-1-Methylquinolin-2(1h)-One
- Staurosporine
- LY-294002
- Imidazole
- (3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One
- Bisindolylmaleimide I
- Quercetin
- Phosphoaminophosphonic Acid-Adenylate Ester
- Dexfosfoserine
- S,S-(2-Hydroxyethyl)Thiocysteine
- IMIDAZOPYRIDAZIN 1
- 4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one
- (4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile
- N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine
- (2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile
- (4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile
- Tricetin
- 6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE
- 4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine
- N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine
- 2,3-diphenyl-1H-indole-7-carboxylic acid
- Fostamatinib
|
|
|
|
PIMREG |
PICALM interacting mitotic regulator |
|
|
|